Neurocrine Biosciences (BSP:N1BI34) Other Long Term Assets : R$2,137 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Neurocrine Biosciences Other Long Term Assets?

Neurocrine Biosciences's other long-term assets for the quarter that ended in Mar. 2024 was R$2,137 Mil.

Neurocrine Biosciences's quarterly other long-term assets declined from Sep. 2023 (R$2,105 Mil) to Dec. 2023 (R$2,020 Mil) but then increased from Dec. 2023 (R$2,020 Mil) to Mar. 2024 (R$2,137 Mil).

Neurocrine Biosciences's annual other long-term assets declined from Dec. 2021 (R$1,807 Mil) to Dec. 2022 (R$1,736 Mil) but then increased from Dec. 2022 (R$1,736 Mil) to Dec. 2023 (R$2,020 Mil).

Neurocrine Biosciences Other Long Term Assets Historical Data

The historical data trend for Neurocrine Biosciences's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurocrine Biosciences Other Long Term Assets Chart

Neurocrine Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

13.13

1,676.14

1,806.74

1,735.70

2,019.70

Neurocrine Biosciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															1,887.08	2,013.80	2,105.37	2,019.70	2,136.83

Neurocrine Biosciences Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Neurocrine Biosciences (BSP:N1BI34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurocrine Biosciences Inc (BSP:N1BI34) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

NBIX:USA NB3:Germany

Address

12780 El Camino Real, San Diego, CA, USA, 92130

Website

https://www.neurocrine.com

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

Neurocrine Biosciences (BSP:N1BI34) Headlines

No Headlines